2004
DOI: 10.1271/bbb.68.939
|View full text |Cite
|
Sign up to set email alerts
|

In VivoBioconversion of Tetrahydroisoquinoline by Recombinant CoclaurineN-Methyltransferase

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
4
0

Year Published

2006
2006
2018
2018

Publication Types

Select...
6
2
1

Relationship

1
8

Authors

Journals

citations
Cited by 15 publications
(4 citation statements)
references
References 8 publications
0
4
0
Order By: Relevance
“…, 2005), exhibit a monophyletic origin (Figure 5). In general, these NMTs accept a wide range of BIA substrates with diverse backbone structures, suggesting a potential utility in metabolic engineering and synthetic biology applications (Morishige et al. , 2004; Hawkins and Smolke, 2008; Minami et al.…”
Section: Discussionmentioning
confidence: 99%
“…, 2005), exhibit a monophyletic origin (Figure 5). In general, these NMTs accept a wide range of BIA substrates with diverse backbone structures, suggesting a potential utility in metabolic engineering and synthetic biology applications (Morishige et al. , 2004; Hawkins and Smolke, 2008; Minami et al.…”
Section: Discussionmentioning
confidence: 99%
“…The improvement of utilization efficiency of dopamine will be needed for in vivo large-scale production. An advantage of this system is that (R,S)-reticuline was produced without the addition of a methyl group donor, S-adenosyl-L-methionine (SAM), because the regeneration of SAM in microbial cells is known to maintain in vivo methylation activity during bioconversion (24).…”
mentioning
confidence: 99%
“…An advantage of fermentative (R,S)-reticuline is that no additional SAM (a methyldonor for methyltransferases) is required, because microbial cells regenerate SAM naturally to maintain in vivo methylation activity during bioconversion. 24 …”
Section: Metabolic Engineering Of Bias In Microbesmentioning
confidence: 99%